Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the OraStem brand; and rapid renew stem cell peptide night cream under the Collect One brand name, as well as Cellect One shield hypochlorous acid skin care products. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.
Frequently asked questions
What sector does Stemtech Corporation (STEK) operate in?
Stemtech Corporation belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Stemtech Corporation (STEK) current stock price?
As of the latest data, Stemtech Corporation stock price is $0.00, with a previous close of $0.00.
What is Stemtech Corporation (STEK) current market capitalization?
Stemtech Corporation market cap is approximately 299.70 thousand.
What is Stemtech Corporation (STEK) Earnings Per Share (EPS)?
The trailing EPS is -$0.01.
What is Stemtech Corporation (STEK) EBITDA?
Stemtech Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -137.75 thousand.
Does Stemtech Corporation (STEK) pay dividends?
No. Stemtech Corporation does not pay a dividend.
What is Stemtech Corporation (STEK) beta (volatility) score?
Stemtech Corporation has a beta of 2.433, indicating very high volatility compared to the market.
